1. Clinical pharmacology of HIV protease inhibitors: focus on saquinavir, indinavir, and ritonavir

   • R.M.W. Hoetelmans
   • C.H.W. Koks
   • D.M. Burger

   Legacy Pages: 159 - 175

2. Why do scientists still study and discuss homeopathy?

   • A. de boer
   • A.J. Porsius

   Legacy Pages: 176 - 177

3. Pharmacoeconomics and therapeutic drug monitoring.

   • J. Lyle Bootman
   • Donald L. Harrison

   OriginalPaper Pages: 178 - 181

4. Scenario analysis of the future of clinical pharmacy.

   • Hubert Leufkens
   • Yechiel Hekster
   • Steve Hudson

   OriginalPaper Pages: 182 - 185

5. Good Practice in the Postmarketing Surveillance of Medicines.

   • R.H.B. Meyboom

   OriginalPaper Pages: 186 - 190

6. Dosage recommendation of vancomycin during haemodialysis with highly permeable membranes.

   • J. Zoer
   • A.M. Schrander-van der Meer
   • W.T. van Dorp

   OriginalPaper Pages: 191 - 196

7. Stability of nystatin in mouthrinses; effect of pH, temperature, concentration and colloidal silver addition, studied using an in vitro antifungal activity.

   • N. Vermerie
   • C. Malbrunot
   • P. Arnaud

   OriginalPaper Pages: 197 - 201

8. Evaluation of drug use and cost of hospital care for aids patients between 1990 and 1994.

   • F. Peyron
   • S. Galliano-Di Bernardo
   • J. Moreau

   OriginalPaper Pages: 202 - 207

9. Falsification of Thai dianabol.

   • P.-H.M. van der Kuy
   • P.M. Hooymans
   • B.J. Looij jr

   Legacy Pages: 208 - 209

10. Involvement of pharmacists in oncology in Europe

    • Gerhard Carstens

    Legacy Pages: 210 - 210

11. Drug resistance.

    • J.H. Beijnen

    BookReview Pages: 211 - 211